Commonly Prescribed Painkillers: What Can be Done to Reduce Risk of Obesity and Sleep Deprivation?
Commonly prescribed painkillers need to be given for shorter periods of time to reduce the risk of obesity and sleep deprivation, a new study has revealed.
Over the past 10 years, there has been a large increase in the prescription of medications such as opioids and some antidepressants for chronic pain management.
Experts at Newcastle University, UK, have today published a study in the academic journal, PLOS ONE, which shows the serious impact of these medications and highlights the need to reduce their use.
Findings show that medications commonly used to treat pain, like gabapentinoids such as gabapentin, pregabilin and opiates, doubled the risk of obesity and were associated with poor sleep.
Scientists assessed the cardio-metabolic health - the inter-relationship between metabolic and cardiovascular disease - in more than 133,000 participants from the UK Biobank.
Body Mass Index, waist circumference and blood pressure were compared between those taking painkillers for chronic, non-cancer pain and cardio-metabolic drugs, compared to those prescribed cardio-metabolic treatment only.
Conditions that can require the use of this treatment include migraine, diabetic neuropathy and chronic lower back pain.
In 2016, 24 million opiates prescriptions were issued in the UK, exactly double the amount of 2006. Two years ago, 11,000 patients were admitted to hospital due to an opiate overdose.
Findings of the new study show people on opiates and cardio-metabolic drugs reported 95% rates of obesity, 82% 'very high' waist circumference and 63% hypertension, as opposed to those on cardio-metabolic drugs only.
Results suggest that chronic pain medications should be prescribed for shorter periods of time to limit serious health complications.
Dr Sophie Cassidy, Research Associate at the Institute of Cellular Medicine, Newcastle University, is lead author of the study.
She said: "In the last two decades there has been a significant increase in the number of people being prescribed both opioid and non-opioid medications to treat chronic pain.
"However, this is the largest study looking at the links between commonly prescribed painkillers and cardio-metabolic health.
"We already know that opiates are dependency-forming but this study also found patients taking opiates have the worst health. Obesity rates are much higher and the patients reported sleeping poorly.
"These results add further weight to calls for these chronic pain medications to be prescribed for shorter periods."
Dangers of opioids
Opioids are recognised as being among the most dangerous prescription painkillers because they are addictive which can lead to them being abused. Patients can require continuous use of the drugs to feel normal and avoid symptoms of withdrawal.
In the last decade, the number prescribed has doubled and long-term use has become increasingly controversial as the medication causes sleep disorders, daytime sedation and accidental overdose.
Dr Kirstie Anderson, Honorary Senior Lecturer at Newcastle University and Consultant Neurologist at Newcastle Hospitals NHS Foundation Trust, co-author of the study, says the findings highlight the risks of overusing strong painkillers.
She said: "There has been recent concern about the addictive nature of opioids and a large number of side-effects, including worsening overnight breathing and therefore disturbing sleep.
"Few studies have looked at the impact of these drugs on metabolism. Our study is the largest of its kind to look at this group of drugs and show an association between obesity and poor sleep.
"Further studies are need to understand how the drugs may affect metabolism over time."
There are a number of possible reasons why opioids can be associated with significant weight gain and obesity.
For example, they can act as a sedative which makes patients less active and they have been shown to alter taste perception with a craving for sugar and sweet foods.
Opioids are also known to worsen snoring and untreated sleep apnea, as well as causing problems with nocturnal hypertension.
This article has been republished from materials provided by Newcastle University. Note: material may have been edited for length and content. For further information, please contact the cited source.
Cassidy, S., Trenell, M. I., & Anderson, K. N. (2017). The cardio-metabolic impact of taking commonly prescribed analgesic drugs in 133,401 UK Biobank participants. Plos One, 12(12). doi:10.1371/journal.pone.0187982
Researchers Move Closer to Completely Optical Artificial Neural NetworkNews
Researchers have shown that it is possible to train artificial neural networks directly on an optical chip. The significant breakthrough demonstrates that an optical circuit can perform a critical function of an electronics-based artificial neural network and could lead to less expensive, faster and more energy efficient ways to perform complex tasks such as speech or image recognition.
Kidney Cancer Driver Could Lead to New Treatment StrategyNews
Scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change can lead to an overabundance of blood vessels, which help feed nutrients to the tumors. Their latest finding shows a potential new cancer-driving pathway.READ MORE
Targeting Headaches and Tumors with Nano-SubmarinesNews
Scientists have developed a new method to enable miniature drug-filled nanocarriers to dock on to immune cells, which in turn attack tumors. In the future, this may lead to targeted treatment that can largely eliminate damage to healthy tissue.READ MORE